La Magie du Normal
Espoir, Amour, et Au-delà
$46.80
- Hardcover
320 pages
- Release Date
13 October 2026
Summary
Un voyage de résilience et d’espoir
Au cœur d’une existence façonnée par l’excellence, de l’Iran à la Silicon Valley, le Dr Maky Zanganeh, PDG visionnaire dans le secteur des biotechnologies, s’est forgée une carrière exceptionnelle. Ses réalisations remarquables à travers de nombreux projets ont toutefois été brusquement interrompues lorsque la vie a placé sur son chemin deux épreuves majeures : une bataille personnelle contre le cancer et le bouleversement mondial des système…
Book Details
| ISBN-13: | 9798901800799 |
|---|---|
| Author: | Maky Zanganeh |
| Publisher: | Advantage Media Group |
| Imprint: | Forbes Books |
| Format: | Hardcover |
| Number of Pages: | 320 |
| Release Date: | 13 October 2026 |
| Weight: | 515g |
| Dimensions: | 152mm x 229mm |
You Can Find This Book In
Maky Zanganeh
Dr. MAKY ZANGANEH has led numerous industry transformations, ranging from minimally invasive surgical robotics to a patient-friendly small molecule drug for blood cancer patients. She is recognized by her colleagues as a leader with a proven track record of bringing unmistakable intensity and clarity to companies that have transformed healthcare for the betterment of humankind. She firmly believes in the concept, “take responsibility and the ability will follow.”
Maky currently serves as the Co-Chief Executive Officer and President, as well as a board member, at Summit Therapeutics, a company dedicated to the development and commercialization of physician and patient-friendly oncology therapies.
Prior to her current role, Dr. Zanganeh was the Chief Operating Officer at Pharmacyclics, a patient-friendly oncology company. There, she spearheaded the transformation of a struggling biotech company, leading to a multi-million dollar collaboration and license deal for ibrutinib with Janssen Biotech Inc. in 2011, and the subsequent sale of the company for $21 billion to AbbVie Inc. in 2015. The deal with Janssen Biotech earned the award for “Best Biotech Transaction” in 2011. Under her leadership in 2015, Pharmacyclics also received the prestigious Prix Galien for “Best Pharmaceutical Agent,” the biomedical industry’s highest accolade recognizing outstanding achievements in new therapy development.
Before Pharmacyclics, Dr. Zanganeh held the position of President of EMEA / Global VP of Training and Education for Computer Motion, Inc., pioneers in robotic surgery, which later merged with Intuitive Surgical Inc. in June 2003.
Dr. Zanganeh holds a DDS (Dental Degree of Surgery) from Louis Pasteur University, France, and an MBA from Schiller International University, France. She is fluent in French, German, Farsi, and English.
Dr. Zanganeh was featured in the article “CEO appointments—21 women who made CEO in 2022” in Business Chief Leadership & Strategy (August 2022). She also received the Fierce Biotech “2013 Top Women in Biotech” award and the Ernst & Young “Entrepreneur of the Year” 2013 award. Recently, Dr. Zanganeh was an honored speaker at the United Nations on February 11, 2022, during the 7th International Day of Women & Girls in Science Assembly conference.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.